Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
akcea therapeutics
alnylam pharmaceuticals
boston
boston blog main
boston top stories
drugs
fda
hereditary transthyretin amyloidosis
inotersen
life sciences
national blog main
national top stories
new york blog main
new york top stories
patisiran
san diego blog main
san diego top stories
tafamidis
barry greene
biotech
boston university
clinical trials
dan ollendorf
european medicines agency
harvard pilgrim health care
institute for clinical and economic review
john berk
mary o'donnell
onpattro
pfizer
regeneron pharmaceuticals
rna interference
san francisco blog main
san francisco top stories
the amyloidosis foundation
the institute for clinical and economic review
vyndaqel
What
alnylam
2
×
fda
medicine
2
×
rna
uses
2
×
ago
approve
approves
awaits
biological
cells
crossed
decades
decision
discovered
drug
ema
employ
europe
fingers
follows
friday
gene
harmful
historic
hits
interference
make
method
mute
patients
protein
rnai
time
trick
way
Language
Current search:
alnylam
×
uses
×
medicine
×
@xconomy.com
6 years ago
RNAi Hits Europe as EMA Follows FDA, Approves Alnylam Drug
@xconomy.com
6 years ago
Patients Have “Fingers Crossed” As Alnylam Awaits Historic FDA Decision